Literature DB >> 6776405

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-1981.

.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 6776405     DOI: 10.1056/NEJM198101013040108

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Glomerular lesions associated with the Crow-Fukase syndrome.

Authors:  M Sano; T Terasaki; A Koyama; M Narita; S Tojo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 2.  Renal lesions in dysproteinemias.

Authors:  P Verroust; L Morel-Maroger; J L Preud'Homme
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Kappa light chain nephropathy. A pathologic study.

Authors:  A R Bangerter; W M Murphy
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

4.  Renal replacement therapy in multiple myeloma and systemic amyloidosis.

Authors:  J H Brown; A P Maxwell; I Bruce; B G Murphy; C C Doherty
Journal:  Ir J Med Sci       Date:  1993-06       Impact factor: 1.568

5.  Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.

Authors:  G Gallo; F Goñi; F Boctor; R Vidal; A Kumar; F J Stevens; B Frangione; J Ghiso
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

6.  [Successful treatment of kappa light chain nephropathy using membrane plasma separation].

Authors:  K B Sprenger; J Galle; I Sprenger-Klasen; J M Herrmann; H E Franz
Journal:  Klin Wochenschr       Date:  1984-10-01

7.  Immunofluorescence characterization of light chains in human nephropathies.

Authors:  C Orfila; J Rakotoarivony; Y Manuel; J M Suc
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

8.  Glomerular capillary aneurysms in light-chain nephropathy. An ultrastructural proposal of pathogenesis.

Authors:  R Sinniah; A H Cohen
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.